Clinical Trial Update: Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial evaluating lumateperone as adjunctive therapy for adults with major depressive disorder has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Lumateperone (lumateperone)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2025-03-25